The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986
Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986
Atypical Ocular Bobbing in Acute Organophosphate Poisoning
Arch Neurol 43:185-186, Hata,S.,et al, 1986
Locus Ceruleus Lesions & Eosinophilic Inclusions in MPTP-Treated Monkeys
Ann Neurol 20:449-455, Forno,L.S.,et al, 1986
Organophosphorus Esters & Polyneuropathy
Ann Int Med 104:264-266, Cherniack,M.G., 1986
Cisplatin Neuropathy with Lhermitte's Sign
JNNP 49:96-99, Dewar,J.,et al, 1986
Azathioprine Toxicity in Neuromuscular Disease
Neurol 36:35-39, Kissel,J.T.,et al, 1986
Neurologic Sequelae of Chronic Solvent Vapor Abuse
Neurol 36:698-702, Hormes,J.T.,et al, 1986
Glutamate & the Pathophysiology of Hypoxic-Ischemic Brain Damage
Ann Neurol 19:105-111, Rothman,S.M.&Olney,J.W., 1986
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Visual & Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
NEJM 314:869-873, Olivieri,N.F.,et al, 1986
Neurologic Complications of Carcinoid
Neurol 36:745-749, Parchell,R.A.&Posner,J.B., 1986
Syndrome of Opsoclonus-Myoclonus in Hyperosmolar Nonketotic Coma
Ann Neurol 18:623-624, Matsumura,K.,et al, 1985
Reversible Myopathy Secondary to Abuse of Ipecac in Patients with Major Eating Disorders
NEJM 313:1457-1459, Palmer,E.P.&Guay,A.T., 1985
Association of High Cyanide & Low Sulphur Intake in Cassava-Induced Spastic Paraparesis
Lancet 2:1211-1213, Cliff,J.,et al, 1985
Treatment of Peripheral Neuropathies
JNNP 48:1193-1207, Hallett,M.,et al, 1985
Peripheral Neuropathy Following Amitriptyline Overdose
Muscle & Nerve 8:723-724985., LeWitt,P.A.&Forno,L.S., 1985
Reversible Ipecac Myopathy
Arch Neurol 42:188-190, Mateer,J.E.,et al, 1985
Neurologic Complications of Bone Marrow Transplantation
Neurol 35:300-306, Patchell,R.A.,et al, 1985
Ommaya Reservoirs in 387 Cancer Patients:A 15-Year Experiment
Neurol 35:1274-1278, Obbens,E.A.M.,et al, 1985
Central Nervous System Toxicity with High-Dose Ara-C
Neurol 35:1475-1479, Hwang,T.,et al, 1985
Acute Vincristine Neurotoxicity
Lancet 1:346, 637-6381985., Arnold,A.M.,et al, 1985
Reverisble, Late-Onset Disulfiram-Induced Neuropathy & Encephalopathy
Ann Neurol 17:396-399, Borrett,D.,et al, 1985
Sensory Neuropathy with Low-Dose Pyridoxine
Neurol 35:1466-1468, Parry,G.J.&Bredesen,D.E., 1985
Neurologic Complications of Systemic Cancer
In Neurologic Clinics 3:729-750, Patchell,R.A.&Posner,J.B., 1985
Long-Lasting Neurological Sequelae After Lithium Intoxication
Acta Psychiatr Scand 70:594-602, Schou,M., 1984
Neurological Complications of Bone Marrow Transplantation in Childhood
Ann Neurol 16:569-576, Wiznitzer,M.,et al, 1984
Seizures in Childhood Lymphoblastic Leukaemia Patients
Lancet 2:1422-1424, Ochs,J.J.,et al, 1984
Brain Metastases & Testicular Tumors:Need for Aggressive Therapy
J Clin Oncology 2:1397-1403, Lester,S.G.,et al, 1984
Diagnosis & Treatment of Lumbosacral Plexopathies in Patients with Cancer
Arch Neurol 41:1282-1285, Pettigrew,L.C.,et al, 1984
Transient Neurologic Dysfunction Following Moderate-Dose Methotrexate for Undifferentiated Lymphoma
Cancer 54:2003-2005, Martino,R.L.,et al, 1984
Cisplatin Neuropathy
Cancer 54:1269-1275, Thompson,S.W.,et al, 1984
Clin Path. Conference
Necrotizing Encephalomyelopath, Secondary to Irradiation & Intrathecal Methotrexate, Case Record 36-, 983, 311:653-662,1984., 1984
Treatment of Massive Intrathecal Methotrexate Overdose by Ventriculolumbar Perfusion
NEJM 311:386-388, Spiegel,R.J.,et al, 1984
Reversible Central Nervous System Dysfunction Due to Tamoxifen in a Patient with Breast Cancer
Ann Int Med 101:652, Pluss,J.L.,et al, 1984
Treatment of Patients with Recurrent Primary Brain Tumors with AZQ
Neurol 34:615-619, Schold,S.C.,et al, 1984
CT Abnormalities & Altered Methotrexate Clearance in Children with CNS Leukemia
Neurol 34:229-233, Duffner,P.K.,et al, 1984
Pentazocine Abuse Masquerading as Familial Myopathy
Neurol 34:524-527, Choucair,A.K.,et al, 1984
Vidarabine Encephalopathy
JNNP 47:1351-1354, Cullis,P.A.,et al, 1984
The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984
Visual Evoked Potentials in the Detection of Subclinical Optic Toxic Effects Secondary to Ethambutol
Arch Neurol 40:645-648, Yiannikas,C.,et al, 1983
Aetiology of Parkinson's Disease
Lancet 2:1457-1459, Calne,D.B.,et al, 1983
Intraventricular Methotrexate Therapy of Leptomeningeal Metastasis from Breast Carcinoma
Neurol 33:1565-1572, OngerboerdeVisser,B.W.,et al, 1983
Paraparesis Following Intrathecal Chemotherapy
Neurol 33:1032-1038, Hahn,A.F.,et al, 1983
Subacute Toxic Delirium Following Nitrous Oxide Abuse
Arch Neurol 40:446-447, Sterman,A.B.,et al, 1983
Myeloneuropathy & Macrocytosis Associated with Nitrous Oxide Abuse
Arch Neurol 40:416-418, Bianco,G.,et al, 1983
Sensory Neuropathy from Pyridoxine Abuse
NEJM 309:445-448, Schaumburg,H.,et al, 1983
Amiodarone Neuropathy
Neurol 33:643-645, Martinez-Arizala,A.,et al, 1983
Rapid Screening for Peripheral Neuropathy:A Field Study with the Optacon
Neurol 33:626-629, Arezzo,J.C.,et al, 1983
Neurotoxicity of Radiological Contrast Agents
Ann Neurol 13:469-484, Junck,L.,et al, 1983